miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling

Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 Benes, 2007, Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars, Proc. Natl. Acad. Sci. U.S.A, 104, 10164, 10.1073/pnas.0703806104 Bomfim, 2012, An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers, J. Clin. Invest., 122, 1339, 10.1172/JCI57256 Braak, 2008, Invited article: nervous system pathology in sporadic Parkinson disease, Neurology, 70, 1916, 10.1212/01.wnl.0000312279.49272.9f Cantuti-Castelvetri, 2007, Effects of gender on nigral gene expression and parkinson disease, Neurobiol. Dis., 26, 606, 10.1016/j.nbd.2007.02.009 Chung, 2005, Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection, Hum. Mol. Genet., 14, 1709, 10.1093/hmg/ddi178 Chung, 2010, Timing-dependent actions of NGF required for cell differentiation, PLoS One, 5, e9011, 10.1371/journal.pone.0009011 Craft, 2004, Insulin and neurodegenerative disease: shared and specific mechanisms, Lancet Neurol., 3, 169, 10.1016/S1474-4422(04)00681-7 Crawford, 2008, MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines, Biochem. Biophys. Res. Commun., 373, 607, 10.1016/j.bbrc.2008.06.090 D'Haene, 2012, miRNA expression profiling: from reference genes to global mean normalization, Methods Mol. Biol., 822, 261, 10.1007/978-1-61779-427-8_18 Das, 2004, Viral evolution as a tool to improve the tetracycline-regulated gene expression system, J. Biol. Chem., 279, 18776, 10.1074/jbc.M313895200 de la Monte, 2012, Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease, Curr. Alzheimer Res., 9, 35, 10.2174/156720512799015037 Deak, 2012, Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1, J.Gerontol A Biol. Sci. Med. Sci., 67, 611, 10.1093/gerona/gls118 Deo, 2011, How to choose a normalization strategy for miRNA quantitative real-time (qPCR) arrays, J. Bioinform. Comput. Biol., 9, 795, 10.1142/S0219720011005793 Doxakis, 2010, Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153, J. Biol. Chem., 285, 12726, 10.1074/jbc.M109.086827 Du, 2011, Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation, J. Mol. Cell. Biol., 3, 176, 10.1093/jmcb/mjq058 Eacker, 2009, Understanding microRNAs in neurodegeneration, Nat. Rev. Neurosci., 10, 837, 10.1038/nrn2726 Elstner, 2011, Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death, Acta Neuropathol., 122, 75, 10.1007/s00401-011-0828-9 Fish, 2008, miR-126 regulates angiogenic signaling and vascular integrity, Dev. Cell, 15, 272, 10.1016/j.devcel.2008.07.008 Friedman, 2009, Most mammalian mRNAs are conserved targets of microRNAs, Genome Res., 19, 92, 10.1101/gr.082701.108 Grimson, 2007, MicroRNA targeting specificity in mammals: determinants beyond seed pairing, Mol. Cell, 27, 91, 10.1016/j.molcel.2007.06.017 Guo, 2008, The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers, Genes Chromosomes Cancer, 47, 939, 10.1002/gcc.20596 Heyer, 2012, Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice, J. Neurosci., 32, 10887, 10.1523/JNEUROSCI.1732-12.2012 Hu, 2013, MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1, Neurosci. Bull., 10.1007/s12264-013-1348-5 Junn, 2009, Repression of alpha-synuclein expression and toxicity by microRNA-7, Proc. Natl. Acad. Sci. U.S.A, 106, 13052, 10.1073/pnas.0906277106 Kefas, 2008, microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma, Cancer Res., 68, 3566, 10.1158/0008-5472.CAN-07-6639 Kim, 2012, Insulin resistance in the nervous system, Trends Endocrinol. Metab., 23, 133, 10.1016/j.tem.2011.12.004 Kim, 2010, Pathological roles of MAPK signaling pathways in human diseases, Biochim. Biophys. Acta, 1802, 396, 10.1016/j.bbadis.2009.12.009 Kim, 2007, A microRNA feedback circuit in midbrain dopamine neurons, Science, 317, 1220, 10.1126/science.1140481 Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035 Liang, 2011, Post-transcriptional regulation of IGF1R by key microRNAs in long-lived mutant mice, Aging Cell, 10, 1080, 10.1111/j.1474-9726.2011.00751.x Ling, 2009, Changes in microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes, Clin. Exp. Pharmacol. Physiol., 36, e32, 10.1111/j.1440-1681.2009.05207.x Mestdagh, 2009, A novel and universal method for microRNA RT-qPCR data normalization, Genome Biol., 10, R64, 10.1186/gb-2009-10-6-r64 Minones-Moyano, 2011, MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function, Hum. Mol. Genet., 20, 3067, 10.1093/hmg/ddr210 Nelson, 2008, MicroRNAs (miRNAs) in neurodegenerative diseases, Brain Pathol., 18, 130, 10.1111/j.1750-3639.2007.00120.x Oglesby, 2010, miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression, J. Immunol., 184, 1702, 10.4049/jimmunol.0902669 Pietersen, 2011, Neuronal type-specific gene expression profiling and laser-capture microdissection, Methods Mol. Biol., 755, 327, 10.1007/978-1-61779-163-5_28 Presgraves, 2004, Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists, Neurotox. Res., 5, 579, 10.1007/BF03033178 Ryu, 2011, The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes, PLoS One, 6, e17343, 10.1371/journal.pone.0017343 Sastry, 2002, Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods, Gene Ther., 9, 1155, 10.1038/sj.gt.3301731 Schapira, 2011, Etiology and pathogenesis of Parkinson's disease, Move. Disord., 26, 1049, 10.1002/mds.23732 Seo, 2004, Generalized brain and skin proteasome inhibition in Huntington's disease, Ann. Neurol., 56, 319, 10.1002/ana.20207 Seo, 2007, Proteasome activator enhances survival of Huntington's disease neuronal model cells, PLoS One, 2, e238, 10.1371/journal.pone.0000238 Sethupathy, 2006, A guide through present computational approaches for the identification of mammalian microRNA targets, Nat. Methods, 3, 881, 10.1038/nmeth954 Simunovic, 2009, Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology, Brain, 132, 1795, 10.1093/brain/awn323 Simunovic, 2010, Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease, PLoS One, 5, e8856, 10.1371/journal.pone.0008856 Sonntag, 2010, MicroRNAs and deregulated gene expression networks in neurodegeneration, Brain Res., 1338, 48, 10.1016/j.brainres.2010.03.106 Sonntag, 2012, Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126, Exp. Neurol., 235, 427, 10.1016/j.expneurol.2011.11.035 Talbot, 2012, Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline, J. Clin. Invest., 122, 1316, 10.1172/JCI59903 Torres-Aleman, 2010, Toward a comprehensive neurobiology of IGF-I, Dev. Neurobiol., 70, 384 Wang, 2008, Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein, Am. J. Hum. Genet., 82, 283, 10.1016/j.ajhg.2007.09.021 Wang, 2008, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis, Dev. Cell, 15, 261, 10.1016/j.devcel.2008.07.002 Wang, 2009, MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats, Clin. Exp. Pharmacol. Physiol., 36, 181, 10.1111/j.1440-1681.2008.05057.x Wirdefeldt, 2011, Epidemiology and etiology of Parkinson's disease: a review of the evidence, Eur. J. Epidemiol., 26, S1, 10.1007/s10654-011-9581-6 Xiao, 2009, miRecords: an integrated resource for microRNA-target interactions, Nucleic Acids Res., 37, D105, 10.1093/nar/gkn851 Yi, 2009, Seeking unique and common biological themes in multiple gene lists or datasets: pathway pattern extraction pipeline for pathway-level comparative analysis, BMC Bioinformatics, 10, 200, 10.1186/1471-2105-10-200 Zhang, 2008, The cell growth suppressor, mir-126, targets IRS-1, Biochem. Biophys. Res. Commun., 377, 136, 10.1016/j.bbrc.2008.09.089 Zhu, 2011, Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2, Mol. Cell Biochem., 351, 157, 10.1007/s11010-011-0723-7 Zufferey, 1997, Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo, Nat. Biotechnol., 15, 871, 10.1038/nbt0997-871 Zufferey, 1998, Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery, J. Virol., 72, 9873, 10.1128/JVI.72.12.9873-9880.1998